Full Text
Full text is available in PDF
An Innovative Journal in the Field of Radiology
e-ISSN 2008-2711
p-ISSN 1735-1065
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence
Authors
Hossein Ghanaati
2,*, Seyed Moayed Alavian3, Ali Jafarian4, Nasser Ebrahimi Daryani5, Mohsen Nassiri-Toosi5, Amir Hossein Jalali2, Madjid Shakiba2
2,*, Seyed Moayed Alavian3, Ali Jafarian4, Nasser Ebrahimi Daryani5, Mohsen Nassiri-Toosi5, Amir Hossein Jalali2, Madjid Shakiba22Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Iran
3Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Iran
4Hepatobilliary and Liver Transplantation Division, Faculty of Medicine, Tehran University of Medical Sciences, Iran
5Department of Gastroenterology, Faculty of Medicine, Tehran University of Medical Sciences, Iran
*Corresponding Author: Medical Imaging Center, Imam Khomeini Hospital, Keshavarz Blvd, [email protected], Iran. Tel: +98-2166581516. Fax: +98-2166581578. Email: [email protected]
Published online:Nov 19, 2012
Article type:Review Article
Received:Sep 18, 2012
Accepted:Oct 27, 2012
How to Cite:Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, et al. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. I J Radiol. 2012;9(4):. doi: https://doi.org/10.5812/iranjradiol.8242
Abstract
The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
10
Oct
2012
Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
Takashi Himoto,
Kazutaka Kurokohchi,
Seishiro Watanabe,
Tsutomu Masaki
Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):5945. doi: https://doi.org/10.5812/hepatmon.5945
12
Apr
2017
Diagnosis and Staging of Hepatocellular Carcinoma
Amir H Davarpanah
Davarpanah AH. Diagnosis and Staging of Hepatocellular Carcinoma. I J Radiol. 2017;14(Special Issue):e48398. doi: https://doi.org/10.5812/iranjradiol.48398
30
Apr
2019
Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI
Sung Mo Kim,
Sang Soo Shin,
Byung Chan Lee,
Jin Woong Kim,
Suk Hee Heo,
Chung Hwan Jun
,et al.Kim SM, Shin SS, Lee BC, Kim JW, Heo SH, et al. Assessment of Treatment Efficacy Immediately After Combined Therapy of Ultrasound-Guided Radiofrequency Ablation and Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Comparison Between Multidetector-Row CT and MRI. I J Radiol. 2019;16(2):e80926. doi: https://doi.org/10.5812/iranjradiol.80926
28
Dec
2014
Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
Kavous Firouznia,
Hossein Ghanaati,
Seyed Moayed Alavian,
Payam Azadeh,
Mohsen Nasiri Toosi,
Arya Haj Mirzaian
,et al.Firouznia K, Ghanaati H, Alavian SM, Azadeh P, Nasiri Toosi M, et al. Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma. Hepat Mon. 2014;14(12):e25792. doi: https://doi.org/10.5812/hepatmon.25792
4
Oct
2016
Outcomes of Transarterial Chemoembolization With or Without Additional Radiofrequency Ablation in Hepatocellular Carcinoma of 2 to 5 cm in Diameter
Mi-Young Kim,
Jin Woong Kim,
Dae-Seong Myung,
Chung-Hwan Jun,
Wan-Sik Lee,
Yang Jun Kang
,et al.Kim M, Kim JW, Myung D, Jun C, Lee W, et al. Outcomes of Transarterial Chemoembolization With or Without Additional Radiofrequency Ablation in Hepatocellular Carcinoma of 2 to 5 cm in Diameter. I J Radiol. 2017;14(1):e13484. doi: https://doi.org/10.5812/iranjradiol.39515
Cited by
- Scopus by DOI: 21
Last Update: 3 weeks ago
- Scopus by Title: 21
Last Update: 3 weeks ago
- Scopus by Title (Ref): 21
Last Update: 3 weeks ago
- CrossRef: 21
Last Update: 3 days ago
Comments
Number of Comments:0